Profit Motives Could Erode AI Tools Doctors Utilize
Aug 06,26 | 01:32 EST
As medical professionals across the nation increasingly integrate artificial intelligence (AI) platforms into their daily practice, a recent viewpoint article featured in JAMA Internal Medicine issues a critical warning: these sophisticated tools possess an inherent vulnerability to a gradual decline in quality over time. Co-authored by Dr. Lindsey Yourman, a distinguished geriatrician and internal medicine physician affiliated with UC San Diego Health, the article underscores the urgent necessity for the establishment of independent standards. These standards are crucial for effectively governing clinician-facing AI tools, particularly before rampant market consolidation potentially compromises their reliability and efficacy. Dr. Yourman highlights a fundamental concern: unlike traditional resources that meticulously cite sources and authors, AI tools often operate as opaque 'black boxes.' This lack of transparency means physicians cannot easily scrutinize the genesis of an AI-generated answer, identify its source material, or determine what critical information might have been excluded. This inherent opaqueness directly contributes to the risk of quality degradation. Furthermore, a significant worry is that, in the absence of stringent oversight, AI platforms could succumb to profit motives. This might lead them to prioritize and steer medical practitioners towards content provided by publishers willing to pay for prominence, rather than presenting the most rigorously evidence-based and clinically relevant data available. Such a scenario could have profound negative implications for patient care, introducing biases and potentially leading to suboptimal treatment decisions.
... read more
